Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pavmed Inc Series Z WT
(NQ:
PAVMZ
)
0.0298
UNCHANGED
Last Price
Updated: 2:19 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pavmed Inc Series Z WT
< Previous
1
2
Next >
PAVmed and Lucid Diagnostics Provide Strategic Business Update
January 17, 2023
From
PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics to Provide Strategic Business Update
January 11, 2023
From
PAVmed Inc.
Via
Business Wire
PAVmed Partners with Novosound on Ultrasound Imaging Technology
December 22, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
December 08, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform
December 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
December 01, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
November 14, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed to Participate in BTIG Digital Health Forum
November 11, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
November 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer
November 09, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022
November 03, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
November 02, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference
August 30, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results
August 16, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
August 11, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
August 04, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America
July 19, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed to Hold a Business Update Conference Call on May 12, 2022
April 26, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference
July 18, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
March 29, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
May 13, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
March 23, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System
March 17, 2022
From
PAVmed Inc.
Via
Business Wire
PAVmed Appoints Shaun O’Neil as Chief Operating Officer
February 24, 2022
From
PAVmed Inc.
Via
Business Wire
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
February 15, 2022
From
PAVmed Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
February 10, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
January 12, 2022
From
PAVmed Inc. and Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
January 06, 2022
From
Lucid Diagnostics Inc.
Via
Business Wire
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
December 01, 2021
From
Lucid Diagnostics Inc.
Via
Business Wire
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
November 17, 2021
From
Lucid Diagnostics Inc. PAVmed Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.